Integra Historical Income Statement

IART Stock

USD 29.24 0.90 3.18%

Historical analysis of Integra LifeSciences income statement accounts such as Total Revenue of 1.6 B or Gross Profit of 458 M can show how well Integra LifeSciences Holdings performed in making a profits. Evaluating Integra LifeSciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Integra LifeSciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Integra LifeSciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Integra LifeSciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Integra Income Statement Analysis

Integra LifeSciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Integra LifeSciences shareholders. The income statement also shows Integra investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Integra LifeSciences Income Statement Chart

Integra LifeSciences Holdings Income Statement is one of the three primary financial statements used for reporting Integra's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Integra LifeSciences revenue and expense. Integra LifeSciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.

At this time, Integra LifeSciences' Net Income Applicable To Common Shares is comparatively stable compared to the past year. Net Income From Continuing Ops is likely to gain to about 75.5 M in 2024, whereas Total Operating Expenses is likely to drop slightly above 383.8 M in 2024.

Total Revenue Gross Profit Other Operating Expenses Research Development

Total Revenue

Total revenue comprises all receipts Integra LifeSciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Integra LifeSciences Holdings minus its cost of goods sold. It is profit before Integra LifeSciences operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Integra LifeSciences. It is also known as Integra LifeSciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Integra LifeSciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Integra LifeSciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Integra LifeSciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Gross Profit	944.6M	970.3M	888.4M	458.0M
Total Revenue	1.5B	1.6B	1.5B	1.6B

Gross Profit Total Revenue

Integra LifeSciences income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Net Income From Continuing Ops	Non Operating Income Net Other	Non Recurring	Discontinued Operations	Tax Provision	Interest Income	Extraordinary Items	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.7	0.58	0.2	0.57	0.5	0.53	0.1	0.79	0.68	0.16	0.15	-0.65	0.17	-0.02	0.2	0.17	0.49	0.36	-0.29	-0.2	-0.1	-0.38	-0.14	0.28
Interest Expense	0.7		0.9	0.69	0.9	0.78	0.78	0.6	0.85	0.92	0.66	0.45	-0.53	0.56	-0.18	0.67	0.47	0.58	0.64	-0.68	-0.58	-0.51	-0.77	-0.74	0.36
Total Revenue	0.58	0.9		0.86	1.0	0.85	0.86	0.81	0.86	0.99	0.84	0.63	-0.39	0.69	-0.05	0.84	0.5	0.64	0.72	-0.74	-0.49	-0.59	-0.8	-0.62	0.18
Gross Profit	0.2	0.69	0.86		0.86	0.73	0.73	0.95	0.61	0.8	0.99	0.68	-0.17	0.75	-0.06	0.98	0.5	0.52	0.72	-0.7	-0.46	-0.57	-0.73	-0.63	0.09
Other Operating Expenses	0.57	0.9	1.0	0.86		0.8	0.81	0.8	0.82	0.99	0.85	0.57	-0.38	0.65	-0.11	0.86	0.45	0.61	0.72	-0.73	-0.53	-0.6	-0.79	-0.62	0.18
Operating Income	0.5	0.78	0.85	0.73	0.8		0.99	0.74	0.92	0.84	0.63	0.84	-0.38	0.8	0.29	0.63	0.73	0.75	0.66	-0.71	-0.25	-0.46	-0.74	-0.49	0.14
Ebit	0.53	0.78	0.86	0.73	0.81	0.99		0.75	0.94	0.85	0.63	0.83	-0.42	0.78	0.3	0.62	0.72	0.76	0.63	-0.7	-0.22	-0.44	-0.74	-0.51	0.14
Research Development	0.1	0.6	0.81	0.95	0.8	0.74	0.75		0.58	0.74	0.92	0.79	-0.04	0.84	0.02	0.89	0.61	0.55	0.56	-0.62	-0.33	-0.53	-0.67	-0.6	-0.03
Ebitda	0.79	0.85	0.86	0.61	0.82	0.92	0.94	0.58		0.89	0.52	0.66	-0.56	0.63	0.21	0.53	0.59	0.75	0.6	-0.62	-0.24	-0.36	-0.69	-0.42	0.22
Cost Of Revenue	0.68	0.92	0.99	0.8	0.99	0.84	0.85	0.74	0.89		0.78	0.58	-0.44	0.64	-0.04	0.79	0.47	0.66	0.7	-0.7	-0.46	-0.53	-0.76	-0.59	0.2
Total Operating Expenses	0.16	0.66	0.84	0.99	0.85	0.63	0.63	0.92	0.52	0.78		0.57	-0.14	0.68	-0.17	1.0	0.4	0.43	0.7	-0.67	-0.52	-0.59	-0.71	-0.63	0.1
Income Before Tax	0.15	0.45	0.63	0.68	0.57	0.84	0.83	0.79	0.66	0.58	0.57		0.11	0.91	0.45	0.54	0.84	0.74	0.52	-0.56	-0.02	-0.38	-0.56	-0.35	-0.24
Total Other Income Expense Net	-0.65	-0.53	-0.39	-0.17	-0.38	-0.38	-0.42	-0.04	-0.56	-0.44	-0.14	0.11		0.05	0.15	-0.16	0.03	-0.18	-0.22	0.2	0.25	-0.02	0.3	0.19	-0.56
Net Income	0.17	0.56	0.69	0.75	0.65	0.8	0.78	0.84	0.63	0.64	0.68	0.91	0.05		0.04	0.65	0.92	0.66	0.52	-0.59	-0.35	-0.57	-0.72	-0.55	-0.12
Income Tax Expense	-0.02	-0.18	-0.05	-0.06	-0.11	0.29	0.3	0.02	0.21	-0.04	-0.17	0.45	0.15	0.04		-0.17	0.12	0.38	0.05	-0.03	0.74	0.32	0.21	0.33	-0.33
Selling General Administrative	0.2	0.67	0.84	0.98	0.86	0.63	0.62	0.89	0.53	0.79	1.0	0.54	-0.16	0.65	-0.17		0.37	0.43	0.73	-0.68	-0.53	-0.59	-0.71	-0.62	0.12
Net Income From Continuing Ops	0.17	0.47	0.5	0.5	0.45	0.73	0.72	0.61	0.59	0.47	0.4	0.84	0.03	0.92	0.12	0.37		0.69	0.41	-0.52	-0.29	-0.51	-0.67	-0.51	-0.14
Non Operating Income Net Other	0.49	0.58	0.64	0.52	0.61	0.75	0.76	0.55	0.75	0.66	0.43	0.74	-0.18	0.66	0.38	0.43	0.69		0.44	-0.51	-0.04	-0.34	-0.56	-0.4	-0.41
Non Recurring	0.36	0.64	0.72	0.72	0.72	0.66	0.63	0.56	0.6	0.7	0.7	0.52	-0.22	0.52	0.05	0.73	0.41	0.44		-0.81	-0.51	-0.56	-0.71	-0.44	0.2
Discontinued Operations	-0.29	-0.68	-0.74	-0.7	-0.73	-0.71	-0.7	-0.62	-0.62	-0.7	-0.67	-0.56	0.2	-0.59	-0.03	-0.68	-0.52	-0.51	-0.81		0.63	0.78	0.86	0.58	-0.13
Tax Provision	-0.2	-0.58	-0.49	-0.46	-0.53	-0.25	-0.22	-0.33	-0.24	-0.46	-0.52	-0.02	0.25	-0.35	0.74	-0.53	-0.29	-0.04	-0.51	0.63		0.75	0.73	0.64	-0.37
Interest Income	-0.1	-0.51	-0.59	-0.57	-0.6	-0.46	-0.44	-0.53	-0.36	-0.53	-0.59	-0.38	-0.02	-0.57	0.32	-0.59	-0.51	-0.34	-0.56	0.78	0.75		0.9	0.58	0.02
Extraordinary Items	-0.38	-0.77	-0.8	-0.73	-0.79	-0.74	-0.74	-0.67	-0.69	-0.76	-0.71	-0.56	0.3	-0.72	0.21	-0.71	-0.67	-0.56	-0.71	0.86	0.73	0.9		0.68	-0.16
Net Interest Income	-0.14	-0.74	-0.62	-0.63	-0.62	-0.49	-0.51	-0.6	-0.42	-0.59	-0.63	-0.35	0.19	-0.55	0.33	-0.62	-0.51	-0.4	-0.44	0.58	0.64	0.58	0.68		-0.2
Reconciled Depreciation	0.28	0.36	0.18	0.09	0.18	0.14	0.14	-0.03	0.22	0.2	0.1	-0.24	-0.56	-0.12	-0.33	0.12	-0.14	-0.41	0.2	-0.13	-0.37	0.02	-0.16	-0.2

Click cells to compare fundamentals

Integra LifeSciences Account Relationship Matchups

Integra LifeSciences income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	27.0M	41.5M	43.0M	37.8M	123.5M	129.7M
Interest Expense	54.0M	71.6M	50.4M	49.6M	71.8M	75.4M
Total Revenue	1.5B	1.4B	1.5B	1.6B	1.5B	1.6B
Gross Profit	952.9M	851.0M	944.6M	970.3M	888.4M	458.0M
Other Operating Expenses	1.4B	1.2B	1.3B	1.3B	1.4B	1.4B
Operating Income	179.0M	151.4M	197.2M	238.9M	174.1M	182.8M
Ebit	179.0M	151.4M	197.2M	238.9M	174.1M	182.8M
Research Development	79.6M	77.4M	93.1M	101.2M	62.7M	44.7M
Ebitda	206.0M	192.9M	240.2M	276.7M	297.6M	312.5M
Cost Of Revenue	564.7M	520.8M	597.8M	587.4M	653.2M	685.8M
Total Operating Expenses	794.2M	699.7M	747.4M	731.4M	714.3M	383.8M
Income Before Tax	60.1M	93.5M	214.7M	213.9M	81.1M	51.6M
Total Other Income Expense Net	(118.9M)	(57.9M)	17.4M	(25.0M)	(93.0M)	(88.4M)
Net Income	50.2M	133.9M	169.1M	180.6M	67.7M	44.1M
Income Tax Expense	9.9M	(40.4M)	45.6M	33.3M	13.3M	7.6M
Selling General Administrative	687.6M	594.5M	637.4M	616.3M	656.6M	339.5M
Net Income Applicable To Common Shares	50.2M	133.9M	169.1M	180.6M	207.6M	218.0M
Net Income From Continuing Ops	50.2M	133.9M	169.1M	180.6M	67.7M	75.5M
Non Operating Income Net Other	20.3M	13.7M	67.8M	24.6M	28.3M	29.7M
Tax Provision	9.9M	(40.4M)	45.6M	33.3M	13.3M	9.1M
Interest Income	10.8M	9.3M	6.7M	11.9M	17.2M	10.1M
Net Interest Income	(43.2M)	(62.3M)	(43.7M)	(37.7M)	(34.2M)	(35.9M)
Reconciled Depreciation	109.5M	116.0M	16.9M	118.3M	123.5M	107.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Integra LifeSciences is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Integra Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Integra Lifesciences Holdings Stock. Highlighted below are key reports to facilitate an investment decision about Integra Lifesciences Holdings Stock:

How To Invest In Integra

Details

Is Integra Stock a good investment?

Details

What is Integra LifeSciences' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Integra Stock analysis

When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.

Is Integra LifeSciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Integra LifeSciences. If investors know Integra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.60)

Earnings Share

0.84

Revenue Per Share

19.248

Quarterly Revenue Growth

(0)

Return On Assets

0.0424

The market value of Integra LifeSciences is measured differently than its book value, which is the value of Integra that is recorded on the company's balance sheet. Investors also form their own opinion of Integra LifeSciences' value that differs from its market value or its book value, called intrinsic value, which is Integra LifeSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Integra LifeSciences' market value can be influenced by many factors that don't directly affect Integra LifeSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Integra LifeSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Integra Historical Income Statement

About Integra Income Statement Analysis

Integra LifeSciences Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Integra LifeSciences income statement Correlations

Integra LifeSciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Integra LifeSciences income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Integra Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Selling General Administrative	+ 1.0	Total Operating Expenses
Cost Of Revenue	+ 0.99	Total Revenue
Total Operating Expenses	+ 0.99	Gross Profit
Cost Of Revenue	+ 0.99	Other Operating Expenses
Ebit	+ 0.99	Operating Income

Discontinued Operations	- 0.81	Non Recurring
Extraordinary Items	- 0.8	Total Revenue
Extraordinary Items	- 0.79	Other Operating Expenses
Extraordinary Items	- 0.77	Interest Expense
Extraordinary Items	- 0.76	Cost Of Revenue
Extraordinary Items	- 0.74	Ebit